Follow the Vistin Pharma ASA stock price and the full management transaction log of the company, a listed issuer based in Norway. Shares are listed on the NO market, under the oversight of Oslo Børs. Operating in the Healthcare & Pharma sector, Vistin Pharma ASA has logged 18 reports. Market capitalisation: €909.1m. The latest transaction was filed on 20 February 2026 (Other). Among the most active insiders: Magnus Tolleshaug. Every trade is free.
18
Insider Decl.
n/a
Thresholds
€2
1 ops.
Buy Volume
€12m
7 ops.
Sell Volume
19Σ signal
Buys €2€12m Sells
Fundamental score
Ranked 1,036 of 29,063 companies
80.9
score / 100
Value
77
Quality
85
FCF yld6.8%
Earn yld8.3%
EV/EBITDA7.4x
ROE22%
Gross mgn51%
Net mgn17%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ NOK 17.3099.5% of flowShareXOSLOSLO:522056
18 of 18 declarations
Acerca de Vistin Pharma ASA
Vistin Pharma ASA es una empresa noruega centrada en el desarrollo y la producción de productos farmacéuticos para el tratamiento de enfermedades metabólicas. Cotiza en la Bolsa de Valores de Oslo bajo el símbolo XOSL.